Quick Order Cart

Cat. No. ARG1577

NAPB Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The NAPB Knockout Raji Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population disrupting the NAPB gene in Raji B lymphocytes. NAPB (beta-SNAP) functions as a cofactor that recruits NSF ATPase to disassemble SNARE complexes formed by syntaxin-1, SNAP-25, and VAMP2, a process triggered by calcium influx. These polyclonal knockout cells enable loss-of-function studies of beta-SNAP in a B-cell lymphoma model, with measurable effects on IgM secretion and surface CD19 expression. Key applications include Western blotting, co-immunoprecipitation, ELISA, flow cytometry, and drug screening for SNARE pathway modulators.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    NAPB

    Gene Identifier

    NCBI Gene ID 63908

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The NAPB Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the human NAPB gene in the Raji B lymphocyte line. This polyclonal product features gene disruption of NAPB, which encodes beta-SNAP, a key mediator of SNARE complex disassembly. Generated via CRISPR/Cas9-mediated gene disruption, the cells provide a loss-of-function model suitable for population-level studies without clonal isolation. The heterogeneous knockout alleles enable robust functional genomic assays and exclude biases from single-cell cloning.

The Raji cell line is a lymphoblastoid line derived from Burkitt lymphoma, characterized by EBV positivity, B-cell surface markers including CD19, and constitutive secretion of IgM. As a suspension line with high transfection efficiency, Raji serves as a classic model for B-cell lymphoma biology and exocytic secretion research. Its well-documented features make it an ideal platform for investigating secretory pathway components in a B-cell context.

NAPB encodes beta-SNAP, a soluble NSF attachment protein that binds to assembled SNARE complexes (comprising syntaxin-1, SNAP-25, and VAMP2) and recruits NSF ATPase. NSF-driven ATP hydrolysis disassembles post-fusion SNARE complexes, enabling vesicle recycling. Beta-SNAP function is regulated by calcium influx and synaptic activity. In B lymphocytes, calcium signals triggered by B-cell receptor engagement may similarly regulate SNARE-dependent secretion. Knockout of NAPB disrupts this disassembly step, leading to impaired SNARE recycling and attenuated exocytosis.

In Raji B cells, beta-SNAP disruption provides a model to study SNARE-mediated exocytosis in the context of immunoglobulin secretion and surface receptor trafficking. The knockout population can be used to assess effects on IgM secretion measured by ELISA and CD19 surface expression by flow cytometry. This model allows dissection of beta-SNAP function in lymphoblastoid secretion and offers a non-neuronal platform to compare SNARE mechanisms, with potential relevance to B-cell effector functions and lymphoma biology.

Researchers can employ these cells for Western blot confirmation of NAPB ablation, RT-qPCR analysis of transcript levels, and co-immunoprecipitation to probe SNARE complex integrity. Functional assays include ELISA for secreted IgM to quantify exocytic output and flow cytometry for surface CD19 to monitor trafficking. The cells are also suitable for drug screening to identify modulators of SNARE assembly/disassembly. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)